title: Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
authors.affiliation: London.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Torjesen
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D000069552:Rivaroxaban; D020521:Stroke / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use; D015091:beta-Alanine / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011728:Pyridones; D015091:beta-Alanine; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran